{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T01:40:13Z","timestamp":1790732413373,"version":"4.1.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2018,4,9]],"date-time":"2018-04-09T00:00:00Z","timestamp":1523232000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Urol"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1007\/s00345-018-2296-5","type":"journal-article","created":{"date-parts":[[2018,4,9]],"date-time":"2018-04-09T07:30:13Z","timestamp":1523259013000},"page":"1455-1460","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Transcutaneous tibial nerve stimulation: 2\u00a0years follow-up outcomes in the management of anticholinergic refractory overactive bladder"],"prefix":"10.1007","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7700-6230","authenticated-orcid":false,"given":"Pierre-Adrien","family":"Leroux","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Brassart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Souhil","family":"Lebdai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdel-Rahm\u00e8ne","family":"Azzouzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Bigot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Carrouget","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,4,9]]},"reference":[{"key":"2296_CR1","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1002\/nau.20798","volume":"29","author":"BT Haylen","year":"2010","unstructured":"Haylen BT, de Ridder D, Freeman RM et al (2010) An International Urogynecological Association (IUGA)\/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Neurourol Urodyn 29:4\u201320. \n                    https:\/\/doi.org\/10.1002\/nau.20798","journal-title":"Neurourol Urodyn"},{"key":"2296_CR2","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1016\/j.eururo.2006.09.019","volume":"50","author":"DE Irwin","year":"2006","unstructured":"Irwin DE, Milsom I, Hunskaar S et al (2006) Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study. Eur Urol 50:1306\u20131315","journal-title":"Eur Urol"},{"key":"2296_CR3","doi-asserted-by":"publisher","first-page":"CD005429","DOI":"10.1002\/14651858.cd005429.pub2","volume":"1","author":"P Madhuvrata","year":"2012","unstructured":"Madhuvrata P, Cody JD, Ellis G et al (2012) Which anticholinergic drug for overactive bladder symptoms in adults. Cochrane Database Syst Rev 1:CD005429. \n                    https:\/\/doi.org\/10.1002\/14651858.cd005429.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"2296_CR4","first-page":"291","volume":"14","author":"AO D\u2019Souza","year":"2008","unstructured":"D\u2019Souza AO, Smith MJ, Miller L-A et al (2008) Persistence, adherence, and switch rates among extended-release and immediate-release overactive bladder medications in a regional managed care plan. J Manag Care Pharm JMCP 14:291\u2013301","journal-title":"J Manag Care Pharm JMCP"},{"key":"2296_CR5","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1002\/nau.20870","volume":"29","author":"P Abrams","year":"2010","unstructured":"Abrams P, Andersson KE, Birder L et al (2010) Fourth international consultation on incontinence recommendations of the international scientific committee: evaluation and treatment of urinary incontinence, pelvic organ prolapse, and fecal incontinence. Neurourol Urodyn 29:213\u2013240. \n                    https:\/\/doi.org\/10.1002\/nau.20870","journal-title":"Neurourol Urodyn"},{"key":"2296_CR6","first-page":"30","volume":"29","author":"K Zinkgraf","year":"2009","unstructured":"Zinkgraf K, Quinn AO, Ketterhagen D et al (2009) Percutaneous tibial nerve stimulation for treatment of overactive bladder and urinary retention in an elderly population. Urol Nurs 29:30\u201334","journal-title":"Urol Nurs"},{"key":"2296_CR7","doi-asserted-by":"publisher","first-page":"CD010098","DOI":"10.1002\/14651858.cd010098.pub4","volume":"12","author":"F Stewart","year":"2016","unstructured":"Stewart F, Gameiro LF, El Dib R et al (2016) Electrical stimulation with non-implanted electrodes for overactive bladder in adults. Cochrane Database Syst Rev 12:CD010098. \n                    https:\/\/doi.org\/10.1002\/14651858.cd010098.pub4","journal-title":"Cochrane Database Syst Rev"},{"key":"2296_CR8","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.urology.2007.11.100","volume":"71","author":"F Haab","year":"2008","unstructured":"Haab F, Richard F, Amarenco G et al (2008) Comprehensive evaluation of bladder and urethral dysfunction symptoms: development and psychometric validation of the urinary symptom profile (USP) questionnaire. Urology 71:646\u2013656. \n                    https:\/\/doi.org\/10.1016\/j.urology.2007.11.100","journal-title":"Urology"},{"key":"2296_CR9","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1002\/nau.20958","volume":"30","author":"M S\u00e8ze De","year":"2011","unstructured":"De S\u00e8ze M, Raibaut P, Gallien P et al (2011) Transcutaneous posterior tibial nerve stimulation for treatment of the overactive bladder syndrome in multiple sclerosis: results of a multicenter prospective study. Neurourol Urodyn 30:306\u2013311. \n                    https:\/\/doi.org\/10.1002\/nau.20958","journal-title":"Neurourol Urodyn"},{"key":"2296_CR10","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1007\/s00192-014-2359-0","volume":"25","author":"M Ammi","year":"2014","unstructured":"Ammi M, Chautard D, Brassart E et al (2014) Transcutaneous posterior tibial nerve stimulation: evaluation of a therapeutic option in the management of anticholinergic refractory overactive bladder. Int Urogynecol J 25:1065\u20131069. \n                    https:\/\/doi.org\/10.1007\/s00192-014-2359-0","journal-title":"Int Urogynecol J"},{"key":"2296_CR11","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1007\/s00192-010-1165-6","volume":"21","author":"L Schreiner","year":"2010","unstructured":"Schreiner L, dos Santos TG, Knorst MR, da Silva Filho IG (2010) Randomized trial of transcutaneous tibial nerve stimulation to treat urge urinary incontinence in older women. Int Urogynecol J 21:1065\u20131070. \n                    https:\/\/doi.org\/10.1007\/s00192-010-1165-6","journal-title":"Int Urogynecol J"},{"key":"2296_CR12","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1016\/S0022-5347(05)66469-5","volume":"165","author":"FE Govier","year":"2001","unstructured":"Govier FE, Litwiller S, Nitti V et al (2001) Percutaneous afferent neuromodulation for the refractory overactive bladder: results of a multicenter study. J Urol 165:1193\u20131198","journal-title":"J Urol"},{"key":"2296_CR13","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/S0090-4295(00)00727-5","volume":"56","author":"HC Klingler","year":"2000","unstructured":"Klingler HC, Pycha A, Schmidbauer J, Marberger M (2000) Use of peripheral neuromodulation of the S3 region for treatment of detrusor overactivity: a urodynamic-based study. Urology 56:766\u2013771","journal-title":"Urology"},{"key":"2296_CR14","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1002\/nau.10111","volume":"22","author":"V Vandoninck","year":"2003","unstructured":"Vandoninck V, van Balken MR, Finazzi Agr\u00f2 E et al (2003) Percutaneous tibial nerve stimulation in the treatment of overactive bladder: urodynamic data. Neurourol Urodyn 22:227\u2013232. \n                    https:\/\/doi.org\/10.1002\/nau.10111","journal-title":"Neurourol Urodyn"},{"key":"2296_CR15","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1016\/j.juro.2009.05.045","volume":"182","author":"KM Peters","year":"2009","unstructured":"Peters KM, MacDiarmid SA, Wooldridge LS et al (2009) Randomized trial of percutaneous tibial nerve stimulation versus extended-release tolterodine: results from the overactive bladder innovative therapy trial. J Urol 182:1055\u20131061. \n                    https:\/\/doi.org\/10.1016\/j.juro.2009.05.045","journal-title":"J Urol"},{"key":"2296_CR16","doi-asserted-by":"publisher","first-page":"2194","DOI":"10.1016\/j.juro.2012.11.175","volume":"189","author":"KM Peters","year":"2013","unstructured":"Peters KM, Carrico DJ, Wooldridge LS et al (2013) Percutaneous tibial nerve stimulation for the long-term treatment of overactive bladder: 3\u00a0years results of the STEP study. J Urol 189:2194\u20132201. \n                    https:\/\/doi.org\/10.1016\/j.juro.2012.11.175","journal-title":"J Urol"},{"key":"2296_CR17","doi-asserted-by":"publisher","first-page":"2210","DOI":"10.1097\/01.ju.0000067446.17576.bd","volume":"169","author":"G Amarenco","year":"2003","unstructured":"Amarenco G, Ismael SS, Even-Schneider A et al (2003) Urodynamic effect of acute transcutaneous posterior tibial nerve stimulation in overactive bladder. J Urol 169:2210\u20132215. \n                    https:\/\/doi.org\/10.1097\/01.ju.0000067446.17576.bd","journal-title":"J Urol"},{"key":"2296_CR18","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1007\/s11255-015-1100-3","volume":"47","author":"H Hashim","year":"2015","unstructured":"Hashim H, Beusterien K, Bridges JFP et al (2015) Patient preferences for treating refractory overactive bladder in the UK. Int Urol Nephrol 47:1619\u20131627. \n                    https:\/\/doi.org\/10.1007\/s11255-015-1100-3","journal-title":"Int Urol Nephrol"},{"key":"2296_CR19","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s00345-013-1112-5","volume":"32","author":"SC Souto","year":"2014","unstructured":"Souto SC, Reis LO, Palma T et al (2014) Prospective and randomized comparison of electrical stimulation of the posterior tibial nerve versus oxybutynin versus their combination for treatment of women with overactive bladder syndrome. World J Urol 32:179\u2013184. \n                    https:\/\/doi.org\/10.1007\/s00345-013-1112-5","journal-title":"World J Urol"}],"container-title":["World Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00345-018-2296-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-018-2296-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-018-2296-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,9]],"date-time":"2019-04-09T01:36:03Z","timestamp":1554773763000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00345-018-2296-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,9]]},"references-count":19,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["2296"],"URL":"https:\/\/doi.org\/10.1007\/s00345-018-2296-5","relation":{},"ISSN":["0724-4983","1433-8726"],"issn-type":[{"value":"0724-4983","type":"print"},{"value":"1433-8726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,9]]},"assertion":[{"value":"5 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}